Overview
- 3 inspections across 3 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-11-11.
At a glance
Inspections
3
Sites
3
Observations
0
Career since
Feb 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Loba Feinchemie GmbH | 11 Nov 2025 | Human Drugs | On file |
| Eli Lilly Kinsale Limited | 15 Mar 2022 | Human Drugs | |
| Novo Nordisk US Bio Production Inc. | 14 Feb 2020 | Biologics | On file |
Sites inspected
Loba Feinchemie GmbHFischamend, Austria1 insp.
Eli Lilly Kinsale LimitedKinsale, Ireland1 insp.
Novo Nordisk US Bio Production Inc.West Lebanon, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Neha Gupta1 shared
Wayne E Seifert1 shared
Maria G Gutierrez-Hoffman1 shared
Yun Wu1 shared
Junho Pak1 shared
Kathleen R Jones1 shared
Full investigator report
Get the verbatim findings behind Arulvathani P Arudchandran's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site